Moll Laurent R - Oct 2, 2025 Form 4 Insider Report for Arteris, Inc. (AIP)

Role
Chief Operating Officer
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R
Stock symbol
AIP
Transactions as of
Oct 2, 2025
Transactions value $
-$495,811
Form type
4
Date filed
10/6/2025, 05:38 PM
Previous filing
Sep 9, 2025
Next filing
Nov 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moll Laurent R Chief Operating Officer C/O ARTERIS, INC., 900 E. HAMILTON AVE., SUITE 300, CAMPBELL /s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R 2025-10-06 0001888601

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIP Common Stock Sale -$20.6K -1.89K -0.49% $10.92 385K Oct 2, 2025 Direct F1
transaction AIP Common Stock Sale -$9.73K -891 -0.23% $10.92 384K Oct 2, 2025 Direct F1
transaction AIP Common Stock Sale -$21K -1.93K -0.5% $10.92 382K Oct 2, 2025 Direct F1
transaction AIP Common Stock Sale -$209K -19.1K -4.99% $10.99 363K Oct 2, 2025 Direct F2, F3
transaction AIP Common Stock Sale -$17.2K -1.55K -0.43% $11.09 361K Oct 3, 2025 Direct F2, F4
transaction AIP Common Stock Sale -$218K -17.2K -4.76% $12.66 344K Oct 6, 2025 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
F2 Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.90 to $11.12 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.83 to $11.29 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.26 to $12.94 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.